Just when I thought I could not take any more outrageous greed!The Federal Trade Commission (FTC) has brought a lawsuit against Ovation Pharmaceuticals that charges the company of illegally raising the price for the only drug that treats heart defects in newborn babies.Ovation acquired the rights to NeoProfen, the only competitor to its own drug, Indocin, in January 2006. Once they owned the
No comments:
Post a Comment